No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NVO Novo-Nordisk A/S
- 139.790
- -2.950-2.07%
Close Jul 11 16:00 ET
- 139.730
- -0.060-0.04%
Post 19:59 ET
622.92BMarket Cap48.20P/E (TTM)
142.530High138.800Low3.84MVolume142.270Open142.740Pre Close537.78MTurnover0.12%Turnover Ratio51.54P/E (Static)4.46BShares148.15052wk High43.24P/B445.91BFloat Cap77.02952wk Low1.37Dividend TTM3.19BShs Float148.150Historical High0.98%Div YieldTTM2.61%Amplitude-3.084Historical Low140.127Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Top Gap Ups and Downs on Thursday: IBKR, DAL, VOD and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Novo Nordisk (NYSE:NVO) Slides After FDA Turns Down Insulin Drug
Hot Research: Lilly's Mounjaro Beats Novo's Ozempic in Weight Loss, Study Says. The Stocks Battle It Out. -- Barrons.com
(The companies mentioned in Hot Research are subjects of research reports issued recently by investment firms. Their opinions do not represent those of Barrons.com or Dow Jones & Company, Inc. Some
Eli Lilly, Novo Nordisk Shares Dip as Pfizer Ramps Up Diabetes Drug Competition
Shares of $Eli Lilly and Co(LLY.US)$ and $Novo-Nordisk A/S(NVO.US)$ finished lower on Thursday, perhaps influenced by competitive developments and regulatory updates in the pharmaceutical sector.
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
Senator Bernie Sanders expressed confidence that Novo Nordisk A/S (NYSE:NVO) can be persuaded to reduce the U.S. prices of its popular weight-loss drugs, Ozempic and Wegovy, by publicly highlighting the disparity between domestic and international pricing.
Express News | Shares of Lilly and Novo Nordisk Are Trading Lower After Pfizer Selected Its Preferred Once-daily Modified Release Formulation for Danuglipron, a GLP-1 Receptor Agonist
Comments
$Novo-Nordisk A/S(NVO.US$ Novo Nordisk receives Complete Response Letter in the US for Thomson Reuters (11/07/2024) Bagsværd, Denmark, 10 July 2024 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has issued a Complete
Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes mellitus. In the letter, the FDA has requests related to the manufac...
Response Letter (CRL) covering the Biologics License Application for once-weekly basal insulin icodec for the treatment of diabetes mellitus. In the letter, the FDA has requests related to the manufac...
2
Fed Chair Powell’s dovish testimony before Congress pushed U.S. stocks to new highs, with $S&P 500 Index(.SPX.US$ and Nasdaq 100 hitting record highs for five consecutive days, and $Nasdaq Composite Index(.IXIC.US$rising for six consecutive days. $Tesla(TSLA.US$ 's ten-day rally has boosted its value by over 43%, adding nearly $240 billion in market cap. The semiconductor index rose 1% before closing down. $NVIDIA(NVDA.US$ opened over 4% higher and closed up 2.5%. $Apple(AAPL.US$ , Lam Res...
6
Morning Movers
Gapping up
$Amazon(AMZN.US$ stock increased by 0.13% after the company unveiled a new $79 Echo Spot alarm clock featuring a refreshed design and enhanced audio quality.
$Intel(INTC.US$ stock leapt 2.68% following a previous session gain of over 6%, with Nvidia also up 1.57% and Marvell rising by 0.69%, as AI-associated stocks continued to gain favor.
$Pfizer(PFE.US$ stock inched up by 0.18% on the news that i...
Gapping up
$Amazon(AMZN.US$ stock increased by 0.13% after the company unveiled a new $79 Echo Spot alarm clock featuring a refreshed design and enhanced audio quality.
$Intel(INTC.US$ stock leapt 2.68% following a previous session gain of over 6%, with Nvidia also up 1.57% and Marvell rising by 0.69%, as AI-associated stocks continued to gain favor.
$Pfizer(PFE.US$ stock inched up by 0.18% on the news that i...
30
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
